美吾華 1731

Listed · Biotechnology and medical care
Backtest

Sign up to add 美吾華 to your watchlist

Sign up to use the watchlist, price alerts and backtests, and keep your personalised settings.

Continue to sign up or sign in

Already have an account? Sign in

21.35▲+0.55 (+2.64%)After close
Prev close
20.8
Volume (shares)
372,869
Data time
2026-11-12 13:30:00
Open
20.95
High
21.50
Low
20.95
Prev close
20.80
Volume (lots)
373
Turnover
0.08 億
P/E
12.3
Cash yield
5.71%

Industry peers: Biotechnology and medical care2026-11-12

Stocks
155
Your rank by market cap
86 / 155
Median P/E
15.1
Median P/B
1.83
Median yield
4.23%
#NameCloseMkt cap (100M)ChangeTurnover (100M)P/EP/BYield
1藥華藥 64461,365.005,766+2.25%75.6560.913.520.11%
2康霈* 691969.501,082-0.71%4.48—12.43—
3禾榮科 7799461.00730+6.71%4.47—6.22—
4沛爾生醫*-創 694940.95537-8.49%10.64—22.83—
5保瑞 6472401.00513-0.50%2.6033.23.402.49%
6美時 1795156.004210.00%1.7311.01.711.64%
7晶碩 6491385.50301-1.78%0.7416.42.612.60%
8晟德 412328.30229-0.35%0.2421.41.256.17%
9合一 474345.65219-1.30%0.47—2.24—
10雙美 4728388.002110.00%0.0526.014.773.12%
11東洋 410583.70208+1.95%1.5812.32.735.38%
12漢達 6620123.00204-9.89%4.0547.44.421.69%
13視陽 6782279.00176-1.24%1.0115.13.673.01%
14中裕 414762.00169+0.16%0.74—4.56—
15漢康-KY創 7827118.50167-0.42%0.16—12.57—
16共信-KY 6617128.00163+1.19%1.29—6.74—
17台康生技 658954.00163+4.45%1.47—1.98—
18永信 370558.70156+1.03%0.0917.21.995.11%
19神隆 178919.65155-1.75%0.151,000.01.421.48%
20高端疫苗 654746.80154+0.97%1.33—4.29—
21健喬 411427.55152-0.72%0.1617.11.613.08%
22長聖 6712145.50146-1.69%0.2132.05.112.41%
23泰合 6467239.00143+3.91%0.89—34.95—
24佳醫 410472.001360.00%0.1115.21.385.97%
25泰博 4736129.00134-0.77%0.284.81.113.93%
26順藥 653577.40130-4.21%0.42—11.41—
27葡萄王 170778.80117+0.13%0.1411.01.1110.03%
28逸達 657672.00113-1.37%0.06521.49.03—
29圓祥生技 6945114.00111-2.98%0.19—4.91—
30生達 172054.90108-0.54%0.1910.81.683.64%
86美吾華 173121.3528+2.64%0.0812.31.205.71%

Active common stocks in the same industry, latest session. P/E and P/B count positive values only. Ranks follow the sorted column and are a data summary, not a rating or advice.